Valesca Retel

Valesca Retel

Netherlands Cancer Institute - Amsterdam / Netherlands
Others
AD Scientific Index ID: 4963266
Nederlands Kanker Instituut
person_outline Valesca Retel's MOST POPULAR ARTICLES
1-) Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) - JM Bueno-de-Mesquita, WH van Harten, VP Retel, LJ van\\\'t Veer, ...
2-) A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study - CA Drukker, JM Bueno‐de‐Mesquita, VP Retèl, WH van Harten, ...
3-) Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma - MW Rohaan, TH Borch, JH Van Den Berg, Ö Met, R Kessels, ...
4-) Impact of organ-on-a-chip technology on pharmaceutical R&D costsN Franzen, WH van Harten, VP Retèl, P Loskill, ...Drug discovery today 24 (9), 1720-1724, 20191552019
5-) Impact of mammographic screening on the detection of good and poor prognosis breast cancersLJ Esserman, Y Shieh, EJT Rutgers, M Knauer, VP Retèl, S Mook, ...Breast cancer research and treatment 130, 725-734, 20111292011